Results 221 to 230 of about 400,796 (284)
Some of the next articles are maybe not open access.
Journal of Urology, 2020
PURPOSE To assess efficacy, safety, and tolerability of vibegron, a novel, potent, highly selective β3-adrenoceptor agonist, administered 12 weeks at 75 mg once-daily to patients with overactive bladder in an international phase III trial with placebo ...
D. Staskin +5 more
semanticscholar +1 more source
PURPOSE To assess efficacy, safety, and tolerability of vibegron, a novel, potent, highly selective β3-adrenoceptor agonist, administered 12 weeks at 75 mg once-daily to patients with overactive bladder in an international phase III trial with placebo ...
D. Staskin +5 more
semanticscholar +1 more source
BJU International, 2020
To determine if there is an increased risk of dementia among patients with overactive bladder (OAB) starting an anticholinergic medication compared to those starting a beta‐3 agonist.
B. Welk, E. McArthur
semanticscholar +1 more source
To determine if there is an increased risk of dementia among patients with overactive bladder (OAB) starting an anticholinergic medication compared to those starting a beta‐3 agonist.
B. Welk, E. McArthur
semanticscholar +1 more source
The Effect of Social Determinants of Health on Overactive Bladder Symptom Severity
Journal of Urology, 2020Purpose: Social determinants of health may significantly impact overall health and drive health disparities. We evaluated the association between social determinants of health and overactive bladder severity.
L. Tellechea +8 more
semanticscholar +1 more source
Oestrogens and overactive bladder
Neurourology and Urodynamics, 2013AbstractEstrogens are known to have a major role in the function of the lower urinary tract although the role of exogenous estrogen replacement therapy in the management of women with lower urinary tract dysfunction remains controversial. Whilst for many years systemic and vaginal estrogen therapy was felt to be beneficial in the treatment of lower ...
Robinson, D. +6 more
openaire +3 more sources
Neurourology and Urodynamics, 2020
This study aims to investigate the efficacy of transcutaneous tibial nerve home stimulation for overactive bladder (OAB) in women with Parkinson's disease (PD).
Tatiane G Araujo +5 more
semanticscholar +1 more source
This study aims to investigate the efficacy of transcutaneous tibial nerve home stimulation for overactive bladder (OAB) in women with Parkinson's disease (PD).
Tatiane G Araujo +5 more
semanticscholar +1 more source
Pharmacotherapy of overactive bladder: epidemiology and pathophysiology of overactive bladder
Expert Opinion on Pharmacotherapy, 2011Overactive bladder (OAB) describes complex symptoms, comprising of urinary urgency, with or without urinary incontinence, often with increased daytime frequency and nocturia in the absence of infection or other obvious etiology. OAB is highly prevalent and affects physical and mental health, activities of daily life and the quality of life of millions ...
Latini JM, GIANNANTONI, Antonella
openaire +3 more sources
Management of Overactive Bladder
New England Journal of Medicine, 2004To the Editor: In his review of the management of overactive bladder (Feb. 19 issue),1 Dr. Ouslander states in Table 1 that cholinesterase inhibitors could theoretically contribute to detrusor overactivity, but he suggests that there is no evidence to support this association. Cholinesterase inhibitors are widely used to manage the symptoms of dementia.
Sudeep S, Gill +2 more
openaire +4 more sources
Pathophysiology of Overactive Bladder
The American Journal of Medicine, 2006Overactive bladder (OAB) is a complex of symptoms frequently encountered in the primary care setting. Impediments to optimal management of OAB include inaccurate perceptions on the part of patients and primary care providers, e.g., that the symptoms of OAB represent a natural progression of aging and are beyond the scope of treatment or that diagnosis ...
Franklin M, Chu, Roger, Dmochowski
openaire +2 more sources
Nursing Standard, 2003
The problem of an overactive bladder is common and can have a major impact on patients' lives. This article describes the possible causes of the condition and the interventions available to help to control it.
openaire +2 more sources
The problem of an overactive bladder is common and can have a major impact on patients' lives. This article describes the possible causes of the condition and the interventions available to help to control it.
openaire +2 more sources
The Medical Letter on Drugs and Therapeutics, 2023
In overactive bladder, involuntary bladder contractions due to detrusor overactivity result in urinary urgency, frequency, nocturia, and incontinence. The prevalence of the disorder increases with age. Nonpharmacologic treatment, including bladder training, urge suppression, pelvic floor muscle exercises, constipation management, modification of fluid ...
openaire +2 more sources
In overactive bladder, involuntary bladder contractions due to detrusor overactivity result in urinary urgency, frequency, nocturia, and incontinence. The prevalence of the disorder increases with age. Nonpharmacologic treatment, including bladder training, urge suppression, pelvic floor muscle exercises, constipation management, modification of fluid ...
openaire +2 more sources